Markets:

Overview

News

Currencies

International

Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

60.98 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

GeneDx to Participate in Fall Investor Conferences

August 12, 2024

From GeneDx

Via Business Wire

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 09, 2024

From GeneDx

Via Business Wire

WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q2 2024 ↗

July 30, 2024

WGS stock results show that GeneDx Hldgs beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients

July 30, 2024

From GeneDx

Via Business Wire

Expert Ratings For GeneDx Hldgs ↗

July 17, 2024

Via Benzinga

The Latest Analyst Ratings For GeneDx Hldgs ↗

June 26, 2024

Via Benzinga

GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights

July 30, 2024

From GeneDx

Via Business Wire

GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing ↗

July 18, 2024

GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and record high margins.

Via Benzinga

GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024

July 11, 2024

From GeneDx Holdings Corp.

Via GlobeNewswire

7 Small-Cap Stocks With Massive Potential Returns ↗

July 06, 2024

Explore these small-cap stocks with high potential in health care, REITs, entertainment, hardware, finance, and distribution industries.

Via InvestorPlace

GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients

June 10, 2024

From GeneDx Holdings Corp.

Via GlobeNewswire

Over $12M Bet On PBF Energy? Check Out These 3 Stocks Insiders Are Buying ↗

June 06, 2024

Via Benzinga

GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients

June 05, 2024

From GeneDx Holdings Corp.

Via GlobeNewswire

Over $4M Bet On ProFrac Holding? Check Out These 3 Stocks Insiders Are Buying ↗

May 29, 2024

Via Benzinga

GeneDx to Participate in Upcoming Investor Conferences

May 22, 2024

From GeneDx Holdings Corp.

Via GlobeNewswire

Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗

May 16, 2024

Via Benzinga

Gold Down Over 2%; 3M Profit Beats Expectations ↗

April 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 30, 2024

Via Benzinga

Eli Lilly Increases FY24 Outlook, Joins Brinker International, Zebra Technologies, 3M And Other Big Stocks Moving Higher On Tuesday ↗

April 30, 2024

Via Benzinga

Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 30, 2024

Via Benzinga

Why GeneDx Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket ↗

April 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 30, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 30, 2024

Our coverage for Tuesday starts with a dive into the biggest pre-market stock movers traders will want to keep an eye on today!

Via InvestorPlace

WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q1 2024 ↗

April 29, 2024

WGS stock results show that GeneDx Hldgs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

GeneDx Stock Climbs After Better-Than-Expected Q1 Results, Raises FY24 Guidance ↗

April 29, 2024

GeneDx reports quarterly losses of 33 cents per share which beat the analyst consensus estimate of losses of 67 cents by 50.75%. The company reported quarterly sales of $62.422 million which beat the...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 29, 2024

Via Benzinga

GeneDx Reports First Quarter 2024 Financial Results and Business Highlights

April 29, 2024

From GeneDx Holdings Corp.

Via GlobeNewswire

GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset

April 23, 2024

The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine

From GeneDx Holdings Corp.

Via GlobeNewswire

GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024

April 04, 2024

From GeneDx Holdings Corp.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 19, 2024

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.